| Rockwell Medical to Present at JMP Securities Healthcare Conference - MarketWatch (press release) |
|
|
MarketWatch (press release) SFP delivers iron to dialysis patients in a non-invasive, physiologic manner via dialysate during their regular dialysis treatment. SFP is currently in ongoing Phase III clinical trials and addresses a $600M US market. Rockwell's Calcitriol (vitamin D |